article · Open MIND
A new pentacyclic saponin named Lomelosin A (<b>1</b>), along with three known compounds (<b>2–4</b>), were isolated from the <i>n</i>-butanol extract of <i>Lomelosia stellata</i>. Their structures were identified through spectroscopic analysis (<sup>1</sup>H- and <sup>13</sup>C-NMR, COSY, HSQC, TOCSY, NOESY and HMBC) and mass spectroscopy (HRESI-MS). Moreover, their molecular docking, pharmacokinetic and toxic parameters were studied. In addition, the <i>in vivo</i> antipyretic activity of the <i>n</i>-butanol extract was evaluated using the Brewer’s yeast-induced pyrexia model. The results showed that all the isolated compounds had excellent binding affinity. The isolates exhibited potential toxicity, but they did not show any hepatotoxicity, mutagenicity or cytotoxicity. Moreover, the administration of the <i>n</i>-butanol extract at 75 mg/kg significantly alleviated pyrexia. This work demonstrates that <i>L. stellata</i> species possesses remarkable antipyretic potential <i>in vivo</i>. The combined structural elucidation, pharmacokinetic studies, and molecular docking suggest that the isolated compounds, particularly Lomelosin A, warrant further investigation as potential therapeutic agents.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.6084/m9.figshare.31434777
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
